Safak Mirioglu retweeted
sadly unaffordable - the last column is estimated annual costs …and we have no idea when they should/can be stopped?
more on the nephjc blog nephjc.com/news/2026/10/21/k…
#KidneyWK
Safak Mirioglu retweeted
Per-protocol repeat kidney biopsy in lupus nephritis: one more branch of the tree
doi.org/10.1093/ndt/gfag249
Safak Mirioglu retweeted
🤔 Is proteinuria harmful after hemodialysis start?
👀 Check out this snapshot summary of another YNP author paper
📝 Beatriz Sanchez Alamo
📱 Post prepared by @jt_nephrology
@NDTsocial @ERAkidney
Safak Mirioglu retweeted
📢 Join us at YNP – EFIM young internists joint e-seminar: "Amyloidosis: Perspectives from Nephrology and Internal Medicine"
📅 November 4, 2026 at 5:00 PM (CET)
📹 Live e-seminar translated into 7 languages
Register now 👉 bit.ly/4yz3oFt
Safak Mirioglu retweeted
A fantastic ERA IWG CME Course 2026 in Łódź, full of inspiring talks and great discussions.
We couldn't have asked for better hosts! 👏
Bravo, @ewa_pawlowicz, Prof. Nowicki and the entire organizing team! 👏
@ERAkidney
Safak Mirioglu retweeted
Not everyone has equal access to kidney care.
@ewa_pawlowicz at #IWG26 highlighting the challenges of managing glomerular diseases in resource-limited settings
An important reminder of the inequalities we still need to address.
Safak Mirioglu retweeted
Repeat kidney biopsies in lupus nephritis! Relevant to dig underneath the tip of the iceberg? @smirioglu @AnnetteBruchfe1 @ERAkidney @StefanieSteige6 @LuvacsL
Safak Mirioglu retweeted
Amazing summary of prognostic models in ANCA and how to implement them by @IMBajema at the ERA IWG CME in Łódź, Poland
Safak Mirioglu retweeted
Approval does not mean access. Improving access to kidney biopsy and newest agents in IgAN must be considered as priority to improve patient outcomes
Thank you for rising this into discussion @smirioglu 🙏🏻🙏🏻🙏🏻
Safak Mirioglu retweeted
Replying to @smirioglu
@smirioglu discussing the newest armamentarium in our fight against IgAN at the ERA IWG CME course 2026
Safak Mirioglu retweeted
The ERA IWG CME Course 2026 kicks off in Łódź! @ERAkidney @ynptweets
@AKronbichler @AnnetteBruchfe1 @smirioglu @IzabelaZakrocka
I completed my #PhD in immunology today! 😊
I want to thank to my mentors and collaborators who helped me throughout the years.
Safak Mirioglu retweeted
Complement activation in secondary thrombotic microangiopathies
doi.org/10.1093/ndt/gfaf091
This review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as a therapeutic strategy.
Safak Mirioglu retweeted
Unmet needs in the management of adult patients with lupus nephritis
doi.org/10.1093/ndt/gfag220
Our new @ERAkidney IWG paper highlights key unmet needs in lupus nephritis: treatment & withdrawal, adherence, biomarkers, repeat biopsy, refractory disease, access to novel therapies, and supportive care!
doi.org/10.1093/ndt/gfag220
@NDTsocial
Safak Mirioglu retweeted
Starting the @ERAkidney education meeting in Kaunas with the great support of the Baltic Nephrology Societies. An incredible opportunity to learn and network.
Safak Mirioglu retweeted
📍 On September 14–15, the Immunonephrology Working Group (IWG) came together at the ERA Headquarters in Parma for its annual face-to-face meeting, a valuable opportunity to review ongoing projects, discuss priorities for the year ahead, and explore new research opportunities.
📸 Here’s a snapshot from the meeting!
A “monstrous” conflict of interest: Kim Fox, ivabradine, and European Society of Cardiology clinical practice guidelines bmj.com/content/394/bmj-2026…
Safak Mirioglu retweeted
🔔 Don’t miss the Immunonephrology Working Group CME Course: “Current Options and Future Opportunities in Glomerular Diseases”
🗓️ October 16–17, 2026
📍 Łódź, Poland
Discover the Scientific Programme and register now 👉 bit.ly/45rz7fL





































